Silicon Laboratories, Inc. (NASDAQ:SLAB - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight brokerages that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $151.1250.
SLAB has been the subject of a number of research reports. KeyCorp boosted their price target on Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Morgan Stanley reduced their price objective on Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research note on Wednesday. Barclays boosted their price objective on Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Susquehanna boosted their price target on Silicon Laboratories from $110.00 to $150.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 22nd. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th.
Check Out Our Latest Stock Report on SLAB
Silicon Laboratories Price Performance
Silicon Laboratories stock traded down $0.40 during mid-day trading on Monday, hitting $123.36. 243,725 shares of the company were exchanged, compared to its average volume of 412,354. The business's 50 day simple moving average is $138.57 and its two-hundred day simple moving average is $128.26. The company has a market capitalization of $4.02 billion, a P/E ratio of -38.24 and a beta of 1.48. Silicon Laboratories has a 12-month low of $82.82 and a 12-month high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%. The business had revenue of $192.85 million for the quarter, compared to analysts' expectations of $192.57 million. During the same quarter last year, the firm earned ($0.56) earnings per share. The business's revenue was up 32.6% on a year-over-year basis. Equities research analysts predict that Silicon Laboratories will post -0.97 earnings per share for the current year.
Insider Activity at Silicon Laboratories
In other Silicon Laboratories news, CEO Robert Matthew Johnson sold 5,879 shares of the company's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the transaction, the chief executive officer owned 73,688 shares in the company, valued at approximately $9,667,865.60. This represents a 7.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Robert J. Conrad sold 4,029 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $528,604.80. Following the completion of the transaction, the senior vice president directly owned 25,380 shares of the company's stock, valued at $3,329,856. This trade represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,080 shares of company stock valued at $1,452,290 over the last ninety days. Corporate insiders own 1.60% of the company's stock.
Hedge Funds Weigh In On Silicon Laboratories
A number of institutional investors and hedge funds have recently added to or reduced their stakes in SLAB. Sei Investments Co. grew its holdings in Silicon Laboratories by 9.8% in the 4th quarter. Sei Investments Co. now owns 13,821 shares of the semiconductor company's stock worth $1,717,000 after buying an additional 1,229 shares in the last quarter. LPL Financial LLC lifted its position in Silicon Laboratories by 36.6% in the fourth quarter. LPL Financial LLC now owns 30,942 shares of the semiconductor company's stock worth $3,994,000 after purchasing an additional 8,289 shares during the period. JPMorgan Chase & Co. lifted its position in Silicon Laboratories by 50.8% in the fourth quarter. JPMorgan Chase & Co. now owns 159,982 shares of the semiconductor company's stock worth $19,873,000 after purchasing an additional 53,890 shares during the period. Norges Bank acquired a new stake in Silicon Laboratories in the fourth quarter worth approximately $34,622,000. Finally, O Shaughnessy Asset Management LLC acquired a new stake in Silicon Laboratories in the fourth quarter worth approximately $214,000.
Silicon Laboratories Company Profile
(
Get Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report